{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:52:49Z","timestamp":1785372769173,"version":"3.55.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chimeric antigen receptor T (CAR-T) cell therapy has achieved remarkable clinical efficacy in treatment of many malignancies especially for B-cell hematologic malignancies. However, the application of CAR-T cells is hampered by potentially adverse events, of which cytokine release syndrome (CRS) is one of the severest and the most studied. Local cytokine-release syndrome (L-CRS) at particular parts of the body has been reported once in a while in B-cell lymphoma or other compartmental tumors. The underlying mechanism of L-CRS is not well understood and the existing reports attempting to illustrate it only involve compartmental tumors, some of which even indicated L-CRS only happens in compartmental tumors. Acute lymphoblastic leukemia (ALL) is systemic and our center treated a B-cell ALL patient who exhibited life threatening dyspnea, L-CRS was under suspicion and the patient was successfully rescued with treatment algorithm of CRS. The case is the firstly reported L-CRS related to systemic malignancies and we tentatively propose a model to illustrate the occurrence and development of L-CRS of systemic malignancies inspired by the case and literature, with emphasis on the new recognition of L-CRS.<\/jats:p>","DOI":"10.3389\/fimmu.2021.707191","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T11:23:55Z","timestamp":1626693835000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective"],"prefix":"10.3389","volume":"12","author":[{"given":"Chengxin","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangbiao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25418","article-title":"An Introduction to Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy for Human Cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0936-4","article-title":"Safety and Efficacy of Chimeric Antigen Receptor (CAR)-T-Cell Therapy in Persons With Advanced B-Cell Cancers and Hepatitis B Virus-Infection","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/sci-2020-029","article-title":"Novel Progresses of Chimeric Antigen Receptor (CAR) T Cell Therapy in Multiple Myeloma","volume":"8","author":"Ding","year":"2021","journal-title":"Stem Cell Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2018.00453","article-title":"CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors","volume":"8","author":"Filley","year":"2018","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2540","article-title":"Preclinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia","volume":"27","author":"Lichtman","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594271","article-title":"Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2020.11.2.4","article-title":"Beyond CAR T-Cell Therapy: Continued Monitoring and Management of Complications","volume":"11","author":"Reiser","year":"2020","journal-title":"J Advanced Practitioner Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.756","article-title":"Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy","volume":"25","author":"Frey","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000160","article-title":"Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-Targeted CAR-T Cells","volume":"40","author":"Tanyi","year":"2017","journal-title":"J Immunotherapy"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0412-1","article-title":"Severe Dyspnea Caused by Rapid Enlargement of Cervical Lymph Node in a Relapsed\/Refractory B-Cell Lymphoma Patient Following Chimeric Antigen Receptor T-Cell Therapy","volume":"54","author":"Jin","year":"2019","journal-title":"Bone Marrow Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-020-00256-x","article-title":"The Model of Cytokine Release Syndrome in CAR T-Cell Treatment for B-Cell Non-Hodgkin Lymphoma","volume":"5","author":"Wei","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated With Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current Concepts in the Diagnosis and Management of Cytokine Release Syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of Chimeric Antigen Receptor T Cells: Recognition and Management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e001511","DOI":"10.1136\/jitc-2020-001511","article-title":"Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immune Effector Cell-Related Adverse Events","volume":"8","author":"Maus","year":"2020","journal-title":"J ImmunoTherapy Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0065-5","article-title":"An \u201cOff-the-Shelf\u201d Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies","volume":"32","author":"Cooper","year":"2018","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-Derived IL-1 and IL-6 Are Differentially Required for Cytokine-Release Syndrome and Neurotoxicity Due to CAR T Cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The Pro- and Anti-Inflammatory Properties of the Cytokine Interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001463","article-title":"Preemptive Mitigation of CD19 CAR T-Cell Cytokine Release Syndrome Without Attenuation of Antileukemic Efficacy","volume":"134","author":"Gardner","year":"2019","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.bbmt.2019.12.603","article-title":"Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed\/Refractory Large B Cell Lymphoma (R\/R LBCL)","volume":"26","author":"Topp","year":"2020","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.707191\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T11:23:57Z","timestamp":1626693837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.707191\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2021.707191"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.707191","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"article-number":"707191"}}